Nitroxoline Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Nitroxoline Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A23065
Buy Now

Nitroxoline Prices December 2023

Product
Category Region Price
Nitroxoline Chemical USA 23095 USD/MT
Nitroxoline Chemical China 815 USD/MT
Nitroxoline Chemical Germany 22757 USD/MT


The price of nitroxoline in the United States touched 23095 USD/MT in December 2023.

The price for nitroxoline in China touched 815 USD/MT in December 2023.

In Germany, nitroxoline prices reached 22757 USD/MT in December 2023.

Nitroxoline Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Nitroxoline Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of nitroxoline pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing nitroxoline price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Nitroxoline Price Trend

Nitroxoline Market Analysis

The global nitroxoline market is projected to grow at a rate (CAGR) of 3.80% during 2023-2032.

  • The market for nitroxoline is rising as the incidence of urinary tract infections (UTIs) increases globally. UTIs are among the most common bacterial infections that are affecting millions of people, particularly women. Some experts say that there is a 50% chance that women will get one UTI in their lifetime, with many having repeat infections, sometimes for years. Also, about 1 in 10 men will get a UTI in their lifetime. Children can get it as well, though this is rare. The infection rate of children is less than 1 or 2 in 100. There are many factors that contribute to this infection’s prevalence, like poor hygiene practices, a rise in diabetes cases, and the geriatric population. Nitroxoline has been used in treating a wide range of UTI-causing bacteria. The frequent occurrence of UTIs, along with recurrent episodes in many patients, is creating a steady demand for effective treatments.
  • The population across the globe is aging, which is creating an increase in the number of geriatric individuals. By 2050, 1 in 6 people on this planet will be over the age of 65. In India, there has been a 41% rise in the population of geriatric people in the last ten years. It is expected that the number of this population group will double by 2025, with 20% of the total population of the country. These adults are more prone to infections due to age-related immunosuppression and the presence of comorbidities such as diabetes and kidney disease. Urinary tract infections (UTIs) are particularly common in this demographic, which creates the need for effective and safe treatment options. Nitroxoline has a favorable safety profile and also gives efficacy in treating UTIs, which makes it an ideal choice for geriatric patients.
  • Expenditure on healthcare is rising because of many factors like economic growth, increased health awareness, and governmental initiatives to better healthcare infrastructure. Enhanced access to healthcare services means more people can receive diagnosis and treatment for infections on time. As healthcare systems expand and more people gain access to medical care, the need and demand for effective treatments like nitroxoline surges. For instance, India's public expenditure on healthcare touched 2.1% of GDP in FY23 and 2.2% in FY22. Similarly, in Europe, the general government spending on health amounted to €1221 billion or 7.7% of GDP in 2022. The U.S. healthcare spending also saw a hike of 4.1%, reaching $4.5 trillion or $13493/person. This hike in budget allocation for healthcare in these countries and several others is known to improve the accessibility and availability of nitroxoline.
  • Chronic diseases like diabetes are impacting the occurrence of infections like UTIs. Diabetic patients are more susceptible to infections because of compromised immune systems and other physiological changes in the body. The increasing incidence of diabetes and related complications is driving the demand for effective antimicrobial treatments like nitroxoline. A total of 38.4 million people have diabetes in the United States. Of these, 29.7 million people, including 29.4 million adults, are already diagnosed, while the other 8.7 million people are undiagnosed. This alarming data has been highlighting the need for effective treatment options in case diabetes excels further to UTI.

Nitroxoline News

The report covers the latest developments, updates, and trends impacting the global nitroxoline market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in nitroxoline production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the nitroxoline industry:

  • In February 2023, Asieris Pharmaceuticals revealed that one of its drugs, APL-1202, helped the University of California, San Francisco, save the life of a man who was suffering from a rare brain-eating amoeba, called Balamuthia mandrillaris. APL-1202 is an investigational drug for treating bladder cancer which contains nitroxoline.

Product Description

Nitroxoline is an antimicrobial agent belonging to the 8-hydroxyquinoline family. It operates by inhibiting bacterial deoxyribonucleic acid (DNA) synthesis, thus preventing bacterial proliferation. The compound exists in oral tablet form and in various formulations, including extended-release tablets and solutions. Nitroxoline is used to treat urinary tract infections (UTIs) caused by bacteria such as Escherichia coli, Staphylococcus saprophyticus, and Enterococcus faecalis. It is also used in managing bacterial prostatitis, pyelonephritis, cystitis, and epididymitis.

Nitroxoline offers numerous benefits, such as its broad-spectrum activity, low resistance rates, and minimal side effects. It also provides several advantages, including high bioavailability, ease of oral administration, and a good safety profile. Moreover, nitroxoline demonstrates effectiveness in acute and chronic infections, making it a versatile option in antimicrobial therapy. Its ability to reach high concentrations in urine is particularly advantageous for UTIs, ensuring effective eradication of pathogens.

Regional Coverage

The report provides a detailed analysis of the nitroxoline market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the price trends. 

Global Nitroxoline Price

The report offers a holistic view of the global nitroxoline pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Nitroxoline Price

European nitroxoline prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed nitroxoline price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.


North America Nitroxoline Price

The analysis of nitroxoline prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific data on nitroxoline prices within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada


Middle East and Africa Nitroxoline Price

The report explores the nitroxoline pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on nitroxoline prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.


Asia Pacific Nitroxoline Price

The nitroxoline pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This analysis can be further extended to include detailed nitroxoline prices for a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.


Latin America Nitroxoline Price

The analysis of nitroxoline prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.


Report Coverage

Key Attributes Details
Product Name Nitroxoline
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
 
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year  
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 

Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of nitroxoline pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting nitroxoline price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the nitroxoline industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Nitroxoline Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually


Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More